5-BPDI

An analogue of a-PHP, which has been described as having an extremely similar effect profile, with some users noting that it may be slightly lighter and with less of an urge to redose. However, little record of the safety of human use exists.

Also known as: Indanyla-α-PHP, Indanily-alfα-PHP

Classification

Psychoactive: Stimulant
Tag: Habit-Forming
Tag: Research-Chemical
Tag: Tentative

Effects

Physical Energy
Loss Of Appetite
Teeth Grinding
Jaw Tension
Insomnia
Itching
Euphoria
Increased Focus
Anxiety
Agitation
Paranoia
Hypervigilance
Light Sensitivity

Routes of Administration

Oral

Dosage

Common: 10-25 mg
Heavy: 45 mg+
Light: 7.5-10 mg
Strong: 25-45 mg
Threshold: 5 mg

Duration

Onset: 0.25-0.5 h
Peak: 1-3 h
Offset: 3-5 h
After Effects: 5-16 h
Total Duration: 4-8 h

Insufflated

Dosage

Heavy: 35 mg+
Light: 5–8 mg
Common: 8–20 mg
Strong: 20–35 mg
Threshold: 3 mg

Duration

Onset: 0.08-0.17 h
Peak: 0.5-2 h
Offset: 2-3.5 h
After Effects: 3.5-24 h
Total Duration: 2-5 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

tripsit.me

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu